https://biotechmorning.com/news/pirtobrutinib-frontline-cll-approval Biotech Morning en 2026-10-03T14:15:15.837Z The Blood Cancer Drug That Skipped the Line https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-2 Biotech Morning en 2026-10-03T14:14:29.658Z Merck KGaA Just Made Its Biggest Bet in a Decade. It's on Lab Supplies. https://biotechmorning.com/news/xaira-ai-antibody-design-platform Biotech Morning en 2026-10-03T14:13:46.744Z The Billion-Dollar Bet That AI Can Skip the Hardest Part of Drug Design https://biotechmorning.com/news/florida-sues-pfizer-covid-vaccine Biotech Morning en 2026-10-03T14:13:03.682Z Florida Just Sued the World's Biggest Vaccine Maker. It's Personal. https://biotechmorning.com/news/heart-valve-grows-with-kid Biotech Morning en 2026-10-03T14:12:22.707Z The Heart Valve That Grows Up With Your Kid https://biotechmorning.com/news/rna-activation-ractigen-dmd-first-in-human Biotech Morning en 2026-10-03T14:11:41.665Z The RNA Trick Nobody Thought Would Work Just Worked in Humans https://biotechmorning.com/news/bayer-2-2-billion-ohio-pharma-manufacturing Biotech Morning en 2026-10-03T14:10:50.717Z Bayer Just Bet $2.2 Billion That Ohio Is the Future of Pharma https://biotechmorning.com/news/generate-biomedicines-400-million-ipo Biotech Morning en 2026-10-03T14:10:06.769Z A Robot Just Raised $400 Million on Wall Street https://biotechmorning.com/news/adarx-446-million-ipo-rna-therapeutics Biotech Morning en 2026-10-03T14:09:24.156Z A $446 Million Bet That RNA Drugs Can Go Anywhere in the Body https://biotechmorning.com/news/regeneron-trevogrumab-muscle-loss-semaglutide Biotech Morning en 2026-10-03T14:08:34.592Z Regeneron's Answer to the Biggest Problem With Ozempic https://biotechmorning.com/news/wave-life-sciences-single-trial-rna-editing-aatd Biotech Morning en 2026-10-02T14:15:39.514Z One Trial to Rule Them All: Wave's Audacious Bet on RNA Editing https://biotechmorning.com/news/regeneron-muscle-mass-wegovy-trevogrumab Biotech Morning en 2026-10-02T14:14:53.759Z Regeneron Found a Way to Give Back the Muscle Wegovy Took https://biotechmorning.com/news/foghorn-lilly-breakup-layoffs Biotech Morning en 2026-10-02T14:14:04.978Z A Mega-Deal Breakup Just Gutted This Biotech's Future https://biotechmorning.com/news/novartis-abogen-mrna-t-cell-engager-deal Biotech Morning en 2026-10-02T14:13:20.562Z Novartis Just Bet $7.8 Billion That Your Body Can Build Its Own Drug Factory https://biotechmorning.com/news/adecto-biotech-shutdown-funding-crisis Biotech Morning en 2026-10-02T14:12:26.856Z The Biotech That Did Everything Right and Still Couldn't Survive https://biotechmorning.com/news/daiichi-astrazeneca-summit-adc-bispecific-combo-trial Biotech Morning en 2026-10-02T14:11:42.354Z Three Pharma Giants Walk Into a Cancer Trial https://biotechmorning.com/news/fresenius-kabi-mabxience-full-acquisition Biotech Morning en 2026-10-02T14:10:54.981Z Why Fresenius Kabi Just Spent €750 Million on a Company It Already Owned https://biotechmorning.com/news/camzyos-first-pediatric-ohcm-approval Biotech Morning en 2026-10-02T14:10:14.712Z The Heart Drug That Just Rewrote the Rules for Sick Teenagers https://biotechmorning.com/news/amgen-horizon-sjogrens-phase-3-win Biotech Morning en 2026-10-02T14:09:28.052Z Amgen's $28 Billion Bet on Horizon Just Got a Whole Lot Smarter https://biotechmorning.com/news/novartis-alteogen-3-2-billion-drug-delivery-deal Biotech Morning en 2026-10-02T14:08:44.085Z Novartis Just Spent $3.2 Billion on a Technology You've Never Heard Of